The most commonly studied GLP-1RA was liraglutide, followed by semaglutide, dulaglutide, tirzepatide, and several others
Key mechanisms: Regulates actin polymerisation, controlling how cells move and restructure tissue Promotes cell migration to sites of injury (fibroblasts, endothelial cells, keratinocytes) Biases healing toward functional tissue formation rather than scar tissue Supports angiogenesis and is documented to promote cardiac, corneal, and dermal wound healing in preclinical models Why it matters for GLP-1 users: Skin that is remodelling under GHK-Cu stimulation and inflammation that is resolving under KPV suppression still requires cells to physically migrate to the remodelling site and organise correctly
It protects against oxidative stress, supports detoxification pathways, and modulates immune function
References to published research throughout this description are provided for informational and research context only and do not constitute medical claims or endorsements of any therapeutic application of this product.
Barouch DH
women-owned brand in collaboration with Koreas top patented oral film innovators
